vascular factor

Subscribe to Selected New Research on vascular factor

85 relevant articles (2 outcomes, 4 trials/studies) found for this Bio-Agent

Description: active portion of hemostatic Zimema consisting of peptides derived from enzymic degradation of Factor VIII (bovine)

Relationship Network

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins

Peptides: 16375

vascular factor: 85

Experts

1.	Dubovaia, T K: 1 article (11/2005)
2.	Bykov, A V: 1 article (11/2005)
3.	Gadziev, Kh K: 1 article (11/2005)
4.	Sergeev, A I: 1 article (11/2005)
5.	Tsibulevskiĭ, A Iu: 1 article (11/2005)
6.	Shchegolev, A I: 1 article (11/2005)
7.	Wang, Min: 1 article (02/2005)
8.	Jia, Jian-ping: 1 article (02/2005)
9.	Da, Yu-wei: 1 article (02/2005)
10.	Takao, Masaki: 1 article (01/2004)

Related Diseases

1.	Ulcer 10/01/1978 - "This proportion of positive results encountered in traumatology and in dermatology for cases where the vascular factor played an important role, makes it possible to consider the application of vibrating electromagnetic waves as a valid therapy for ulcers." 01/01/1992 - "A possible role of vascular factor in the genesis of ulcer formation." 09/01/1996 - "We conclude that TGF-beta 1 accelerates ulcer healing possibly by increasing the formation of granulation tissue and cell migration probably mediated by locally expressed TGF-beta 1 but the healing effects of TGF-beta 1 do not depend on the vascular factor." Order ALL the reference details at left...
2.	Hemorrhage 01/01/1989 - "Bleeding tendency of chronic uremia improved by vascular factor." 03/01/1957 - "[Role of the vascular factor in the mechanism of hemorrhage development in aplastic and hypoplastic anemia.]" 01/01/1989 - "The anticoagulant effect of administered heparin does not produce hemorrhage since this requires simultaneous occurrence of defects in the vascular factor of hemostasis (the result of stress or pituitary-adrenal imbalance) or platelet defect. " Order ALL the reference details at left...
3.	Uremia 01/01/1989 - "Bleeding tendency of chronic uremia improved by vascular factor." Order ALL the reference details at left...
4.	Ischemia 01/01/1994 - "However, these differences do not indicate per se a leading role of the vascular factor in the pathomechanism of selective vulnerability to ischemia. " 03/01/2000 - "Our studies show that ischemia-induced the Alzheimer-associated gene presenilin 1 (PS1) and endoplasmic reticulum-stress, generated from a vascular disorder, may unmask clinical AD symptoms caused by presenilin mutation, suggesting that a vascular factor might be involved in the onset of familial AD." Order ALL the reference details at left...
5.	Hemorrhagic Disorders (Hemorrhagic Diathesis) 04/01/1975 - "An electron microscopic study of the vascular factor in hemorrhagic diathesis." 05/15/1966 - "[Electron microscopic and histochemical findings on the problem of the so-called vascular factor in hemorrhagic diathesis]" Order ALL the reference details at left...

Related Drugs and Biologics

1.	Presenilin-1
2.	Presenilins
3.	Transforming Growth Factor beta1 (TGF beta 1)
4.	17-Hydroxycorticosteroids
5.	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)
6.	Heparin (Liquaemin)
7.	Gold
8.	Factor VIII (Coagulation Factor VIII)
9.	Calcium

Related Therapies and Procedures

1.	Traction

Best Treatments:
Research Summary Report
on Ulcer

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 1182 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>